Clinical Trial: Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Germ Cell Tumor
Study Type: INTERVENTIONAL
Official Title: Clinical Study of Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor in Children
Brief Summary:
Remarkable progress has been made in treating germ-cell tumor (GCT) through the use of platinum-based regimens.However, part of yolk sac tumor (YST) with cisplatin resistance or recurrence is nevertheless prone to relapse after second-line treatment.This leaves a gap in effective treatment, which needs to be filled by novel therapeutic approaches.This paper is the first one to report the treatment combining thalidomide with nab-paclitaxel, gemcitabine, and epirubicin (T-TGA) for children with repeated relapsed or…
Read more